$2.755
-0.208 (-7.55%)收盤時
CNSY 獲利能力與利潤率
Evaluating the bottom line, Cerenome, Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -2203.65%, while the net margin is -2191.24%. These profitability ratios, combined with a Return on Equity (ROE) of -614.05%, provide a clear picture of how effectively CNSY converts its operational activities into shareholder value.
CNSY 同業比較
In the context of the broader market, CNSY competes directly with industry leaders such as GNTA and BFRI. With a market capitalization of $22.31M, it holds a significant position in the sector. When comparing efficiency, CNSY's gross margin of 100.00% stands against GNTA's N/A and BFRI's 79.92%. Such benchmarking helps identify whether Cerenome, Inc is trading at a premium or discount relative to its financial performance.
CNSY 財務表現
The company has reported significant net losses, with a net income of -9006000 in Q2 2026 and a negative EPS of -1.31. Furthermore, the gross margin remains at 100%, but this does not compensate for the overall negative financial outlook.
Financials
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。